Nachrichten zur Akebia Therapeutics Inc. Aktie

Why Are Akebia Therapeutics Shares Falling Today?

Akebia falls as agreement with Otsuka Pharma ends

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Akebia Therapeutics, For: May 12

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AKBA SHAREHOLDER ALERT: Jakubowitz Law Reminds Akebia Shareholders of a Lead Plaintiff Deadline of May 13, 2022

NEW YORK, May 13, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…

AKBA LAWSUIT ALERT: Levi & Korsinsky Notifies Akebia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, May 12, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Akebia Therapeutics, Inc. ("Akebia" or the…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Akebia Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 13, 2022 - (NASDAQ: AKBA)

NEW YORK, May 11, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Akebia Therapeutics,…

AKBA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 13, 2022 in the Class Action Filed on Behalf of Akebia Therapeutics, Inc. Shareholders

NEW YORK, May 10, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…

AKBA SHAREHOLDER ALERT: Jakubowitz Law Reminds Akebia Shareholders of a Lead Plaintiff Deadline of May 13, 2022

NEW YORK, May 6, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…

AKBA LAWSUIT ALERT: Levi & Korsinsky Notifies Akebia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, May 5, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Akebia Therapeutics, Inc. ("Akebia" or the…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akebia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AKBA

NEW YORK, May 3, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Akebia…

Akebia Therapeutics to Report First Quarter Financial Results

Akebia to Host Conference Call to Provide Business Update CAMBRIDGE, Mass., May 2, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq:…

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Akebia Investors of a Lead Plaintiff Deadline of May 13, 2022

NEW YORK, May 2, 2022 /PRNewswire/ -- Attention Akebia Therapeutics, Inc. ("Akebia") (NASDAQ: AKBA) shareholders: The Law Offices of Vincent…

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important May 13 Deadline in Securities Class Action - AKBA

NEW YORK, April 29, 2022 /PRNewswire/ -- WHY:Rosen Law Firm, a global investor rights law firm, reminds purchasers of the…

AKBA LAWSUIT ALERT: Levi & Korsinsky Notifies Akebia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, April 28, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Akebia Therapeutics, Inc. ("Akebia" or the…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Akebia Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 13, 2022 - (NASDAQ: AKBA)

NEW YORK, April 27, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Akebia Therapeutics,…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akebia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AKBA

NEW YORK, April 25, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Akebia…

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Akebia Investors of a Lead Plaintiff Deadline of May 13, 2022

NEW YORK, April 25, 2022 /PRNewswire/ -- Attention Akebia Therapeutics, Inc. ("Akebia") (NASDAQ: AKBA) shareholders: The Law Offices of Vincent…

AKBA LAWSUIT ALERT: Levi & Korsinsky Notifies Akebia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, April 21, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Akebia Therapeutics, Inc. ("Akebia" or the…

AKBA INVESTOR NOTICE: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

NEW YORK, April 20, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Akebia Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 13, 2022 - (NASDAQ: AKBA)

NEW YORK, April 20, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Akebia Therapeutics,…

AKBA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 13, 2022 in the Class Action Filed on Behalf of Akebia Therapeutics, Inc. Shareholders

NEW YORK, April 19, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Akebia Investors of a Lead Plaintiff Deadline of May 13, 2022

NEW YORK, April 18, 2022 /PRNewswire/ -- Attention Akebia Therapeutics, Inc. ("Akebia") (NASDAQ: AKBA) shareholders: The Law Offices of Vincent…

AKBA SHAREHOLDER ALERT: Jakubowitz Law Reminds Akebia Shareholders Of A Lead Plaintiff Deadline Of May 13, 2022

NEW YORK, April 15, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…

AKBA INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

NEW YORK, April 13, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders Of Akebia Therapeutics, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of May 13, 2022 - (NASDAQ: AKBA)

NEW YORK, April 13, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Akebia Therapeutics,…

AKBA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 13, 2022 in the Class Action Filed on Behalf of Akebia Therapeutics, Inc. Shareholders

NEW YORK, April 12, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akebia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AKBA

NEW YORK, April 11, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Akebia…

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Akebia Investors of a Lead Plaintiff Deadline of May 13, 2022

NEW YORK, April 11, 2022 /PRNewswire/ -- Attention Akebia Therapeutics, Inc. ("Akebia") (NASDAQ: AKBA) shareholders: The Law Offices of Vincent…

AKBA SHAREHOLDER ALERT: Jakubowitz Law Reminds Akebia Shareholders Of A Lead Plaintiff Deadline Of May 13, 2022

NEW YORK, April 8, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…

See Why Does HC Wainwright Maintain Neutral On Akebia Stock

Akebia Therapeutics Inc (NASDAQ: AKBA) announced three poster presentations at the National Kidney Foundation (NKF) Spring Clinical Meetings 2022. Latest…

FDA Places Partial Hold On Vadadustat Pediatric Studies, Akebia Cuts Over 40% Staff

Form 8-K Akebia Therapeutics, For: Apr 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

AKBA LAWSUIT ALERT: Levi & Korsinsky Notifies Akebia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, April 7, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Akebia Therapeutics, Inc. ("Akebia" or the…

ROSEN, A LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

NEW YORK, April 6, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders Of Akebia Therapeutics, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of May 13, 2022 - (NASDAQ: AKBA)

NEW YORK, April 6, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Akebia Therapeutics,…

AKBA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 13, 2022 in the Class Action Filed on Behalf of Akebia Therapeutics, Inc. Shareholders

NEW YORK, April 5, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 4, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better…

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Akebia Investors of a Lead Plaintiff Deadline of May 13, 2022

NEW YORK, April 4, 2022 /PRNewswire/ -- Attention Akebia Therapeutics, Inc. ("Akebia") (NASDAQ: AKBA) shareholders: The Law Offices of Vincent…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akebia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AKBA

NEW YORK, April 3, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Akebia…

AKBA SHAREHOLDER ALERT: Jakubowitz Law Reminds Akebia Shareholders of a Lead Plaintiff Deadline of May 13, 2022

NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…

Akebia extends slide as Wall Street reacts to FDA rejection of kidney disease drug

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

AKBA LAWSUIT ALERT: Levi & Korsinsky Notifies Akebia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, March 31, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Akebia Therapeutics, Inc. ("Akebia" or the…

Form 8-K Akebia Therapeutics, For: Mar 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia Therapeutics plummets 64% on Complete Response Letter for vadadustat

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Akebia falls as FDA rejects kidney disease therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

FDA Says Akebia Therapeutics Vadadustat Application Not Ready for Approval

FDA Says Akebia Therapeutics' Vadadustat Application Not Ready for Approval...…

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

NEW YORK, March 30, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…

Akebia Therapeutics Receives Complete Response Letter from the FDA for Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients

Company to host conference call on Wednesday, March 30, 2022 at 6:00 p.m. ET CAMBRIDGE, Mass., March 30, 2022 /PRNewswire/…

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia

Heres a roundup of top developments in the biotech space over the last 24 hours: read more...…

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money…